Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating emergency surgery for severe brain hemorrhage patients on long-term antiplatelet treatment

Official title: China Research for Severe Spontaneous Intracerebral Hemorrhage(CRISIH)

Run by Beijing Tiantan Hospital · NCT05975398 · Data updated 2026-11-12

This study is trying to see if emergency surgery can help people with severe brain bleeding who are taking blood-thinning medications and how safe it is for them.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedNovember 1, 2019
Main results expectedDecember 30, 2029
Study endsDecember 31, 2030
Registry record updatedJuly 10, 2026
Trial IDNCT05975398 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18-75 with severe non-traumatic intracerebral hemorrhage and a Glasgow coma score of less than 13.

Probably not a fit

Patients with underlying cerebrovascular diseases, tumors, or severe coagulation disorders are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to assess the effects and safety of emergency surgery in patients suffering from severe spontaneous intracerebral hemorrhage (SSICH) who are on long-term oral antiplatelet treatment. Conducted across seven clinical centers, the study will recruit 450 patients and monitor them for clinical, radiological, and laboratory outcomes until death or six months post-hemorrhage. The study began in September 2019 and is set to conclude in December 2022, focusing on understanding the implications of surgical intervention in this specific patient population.

Why it matters

Potential benefit: If successful, this study could provide critical insights into the safety and efficacy of emergency surgical interventions for patients with severe brain hemorrhages who are on antiplatelet therapy.

How similar studies have gone: While the specific approach of this study may be novel, similar studies have indicated the importance of understanding surgical outcomes in patients with complex medical histories.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18 years or older.
2. Spontaneous, nontraumatic intracerebral hemorrhage.
3. Treatment with surgical or conservative management according to clinical indications and routine clinical practice.
4. Written informed consent provided by the patient or legally authorized representative/family member.

Exclusion Criteria:

1. Patients had cerebrovascular diseases associated with hemorrhage, such as intracranial aneurysm, cerebrovascular malformation, or intracranial tumors.
2. Hemorrhagic transformation of cerebral infarction.
3. Hemorrhage caused by cerebral venous thrombosis.
4. Patients with severe coagulation disorder, such as hemophilia.
5. Patients with coagulation dysfunction caused by malignant tumor, hepatic insufficiency, renal dysfunction, thrombocytopenia, coagulation diseases, or related conditions.
6. Patients receiving other anticoagulation medications, including vitamin K antagonists or novel oral anticoagulants.
7. Patients who died before arrival at the hospital, on arrival at the hospital, or within a short period (6 hours) after admission.

Where it's running

  • Capital Medical University Affiliated Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.